| Unknown | Tenofovir/Levonorgestrel Intravaginal Ring and Tenofovir Intravaginal Ring HIV, Contraception, Prevention | Phase 2 | 2018-12-12 |
| Completed | Safety, PK, and PD Study of a Vaginal Insert Containing TAF and EVG Hiv, HSV | Phase 1 | 2018-12-10 |
| Completed | Safety, PK, and PD Study of IVRs Releasing TFV and LNG Anti-Infective Agents, Anti-Retroviral Agents, Contraceptive Usage | Phase 1 | 2017-09-28 |
| Completed | PK and PD Study of Oral F/TAF for HIV Prevention HIV | Phase 1 | 2016-10-06 |
| Completed | The Quatro Study: Acceptability Study of (Placebo) Vaginal Delivery Forms for Preventing HIV and Unintended Pr HIV, Contraception | N/A | 2016-06-06 |
| Completed | Exploratory Pharmacodynamic Study of Tenofovir-Based Products HIV | Phase 1 | 2016-04-01 |
| Completed | Development of Adherence Biomarkers for Multiple Microbicide and Multipurpose Prevention Technology (MPT) Dosa HIV | Phase 1 | 2015-10-01 |
| Completed | Assessing the Disintegration, Safety, and Acceptability of Placebo Vaginal Inserts for the Delivery of Vaginal Vaginal Diseases | N/A | 2015-08-01 |
| Completed | A Safety Study Of The Caya® Diaphragm Used With ContraGel® Contraception | Phase 1 | 2015-07-01 |
| Completed | Postcoital Testing Study of the SILCS Diaphragm Used With 3% N-9 Gel, ContraGel, or No Gel Contraception | Phase 1 | 2014-12-01 |
| Completed | Comparison of Tenofovir Vaginal Gel and Film Formulations Healthy, HIV | EARLY_Phase 1 | 2014-11-01 |
| Completed | Phase I One-month Safety, PK, PD, and Acceptability Study of IVR Releasing TFV and LNG or TFV Alone HIV, Contraception | Phase 1 | 2014-10-01 |
| Completed | The Role of Vitamin D in Female Reproductive Tract Immunity Vitamin D Deficiency | Phase 1 | 2014-08-01 |
| Completed | Tenofovir Levels Following Local Application of Tenofovir Reduced-Glycerin 1% Gel HIV Prevention | Phase 1 | 2014-04-01 |
| Completed | In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal Products HIV Prevention | Phase 1 | 2013-12-01 |
| Completed | A Phase I Trial to Assess the Safety of Tenofovir Gel and Film Formulations: FAME 04 HIV | Phase 1 | 2013-11-01 |
| Completed | Safety and Acceptability Study of Oral Emtricitabine/Tenofovir Disoproxil Fumarate Tablet and Rectally-Applied HIV | Phase 2 | 2013-09-25 |
| Completed | Influence of Reproductive Cycle and Menopause on HIV-1 Infection and TFV Gel Activity HIV Prevention | Phase 1 | 2013-09-01 |
| Completed | Biomarkers of Protocol Compliance and Product Adherence HIV Prevention | — | 2013-03-01 |
| Completed | Safety, Pharmacokinetics, Pharmacodynamics, and Disintegration Time of Vaginal Tablets Containing Tenofovir an HIV | Phase 1 | 2013-02-01 |
| Completed | Coital Pharmacokinetics/Pharmacodynamics (PK/PD) of Tenofovir Gel Pharmacokinetics of 1% Tenofovir Gel Following Coitus, Pharmacodynamics of 1% Tenofovir Gel Following Coitus | Phase 1 | 2012-11-01 |
| Completed | Identification of Novel Biomarkers of Cervicovaginal Mucosal Inflammation Vaginal Inflammation, Vaginal Infections | Phase 2 | 2012-05-01 |
| Completed | Contraception and Menstrual Cycle Effect on Pharmacokinetics, Pharmacodynamics and Safety in Tenofovir Vaginal HIV Prevention | Phase 1 | 2012-03-01 |
| Completed | Pharmacokinetic and Pharmacodynamic Study of Tenofovir 1% Gel Prevention | Phase 1 | 2012-01-01 |
| Completed | Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection HIV Prevention | Phase 3 | 2011-10-01 |
| Completed | Study of How Bacterial Vaginosis and Its Treatment Affects Cervical and Vaginal Tissue Bacterial Vaginosis, Vaginal Discharge | N/A | 2011-04-01 |
| Completed | Rectal Safety and Acceptability Study of Tenofovir 1% Gel Rectal Microbicides | Phase 1 | 2010-10-01 |
| Completed | Microbicide Safety and Acceptability in Young Men High Risk MSM, HIV Negative, 18-30 Years of Age | Phase 1 | 2010-10-01 |
| Completed | Prostate Specific Antigen (PSA) and Acute Failure Modes Study of the PATH Woman's Condom and FC2 Female Condom Birth Control | N/A | 2010-07-01 |
| Completed | Rectal Microbicide Safety and Acceptability Trial of Topically Applied Tenofovir Compared With Oral Tablet HIV Prevention, HIV Infections | Phase 1 | 2009-09-01 |
| Completed | Residence Time of Biomarkers of Semen Exposure Semen Exposure | — | 2008-12-01 |
| Completed | Contraceptive Effectiveness and Safety of the SILCS Diaphragm Contraception | Phase 2 / Phase 3 | 2008-01-01 |
| Completed | Pharmacokinetic Study of the Vaginal Microbicide Agent 1% Tenofovir Gel HIV Infections | Phase 1 | 2007-03-01 |
| Completed | Study of UC-781 Vaginal Microbicide HIV Infections | Phase 1 | 2005-10-01 |
| Terminated | Cellulose Sulfate and HIV Transmission Among Women HIV Infection | Phase 3 | 2005-07-01 |
| Completed | Contraceptive Effectiveness Trial of Cellulose Sulfate Gel Contraception | Phase 2 | 2005-01-01 |
| Completed | Postcoital Testing of the SILCS Diaphragm Contraceptive Device | Phase 1 | 2003-08-01 |
| Withdrawn | Paper Applicator Acceptability Study HIV Prevention | Phase 1 / Phase 2 | — |
| Withdrawn | Safety and Acceptability of Tenofovir 1% Gel in Adolescent Females HIV Prevention | Phase 1 | — |